Stay updated on Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-19T12:11:06.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-12T14:24:37.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, indicating a new revision of the record in the History section.
    Difference
    0.0%
    Check dated 2026-09-21T20:35:38.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page history now includes a new Revision: v3.6.6 entry, replacing the previous Revision: v3.6.5. This reflects a small update to the page's revision metadata and does not alter the visible trial information.
    Difference
    0.0%
    Check dated 2026-08-31T17:33:12.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The Record History page now shows revision v3.6.5, replacing v3.6.4. This signals a small platform update to the page rendering rather than any change to trial data.
    Difference
    0.0%
    Check dated 2026-08-10T11:41:02.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, reflecting a minor system update to the record history interface. No study content or historical entries are modified.
    Difference
    0.0%
    Check dated 2026-07-27T06:21:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.